PATRICIA EJOH: Open Payments
NPI 1710453303 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 36 payments from 14 companies in 2025. Trend: 2023 $409 · 2024 $1,198 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $96 |
| ABBVIE INC. | 5 | $92 |
| Neurocrine BioSciences, Inc. | 3 | $82 |
| Supernus Pharmaceuticals, Inc. | 4 | $79 |
| Janssen Pharmaceuticals, Inc | 2 | $68 |
| Alkermes, Inc. | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Janssen Scientific Affairs, LLC | 1 | $26 |
Products named: CAPLYTA, INVEGA SUSTENNA, VRAYLAR, ABILIFY MAINTENA, INGREZZA, Qelbree, Jornay PM, ARISTADA.
Industry payments across MD — which companies pay providers there.
